Breast Cancer
News
ASCO details how to manage ongoing cancer drug shortage
“This guidance document aims to support clinicians, as they navigate the complexities of treatment planning amid the drug shortage.”
News
Avoid anti-HER2 cancer therapies during pregnancy
Exposure to anti-HER2 agents was associated with “severe specific adverse pregnancy and fetal or newborn outcomes compared with exposure to other...
News
Breast milk liquid biopsy under study for early-stage breast cancer detection
Just like taking a small blood sample from newborns in a heel-prick test to rule out metabolic diseases, milk samples could be taken from women...
News
Can a Mediterranean diet reduce breast cancer recurrence?
A growing body of evidence suggests that a better dietary quality may improve survival among patients with breast cancer, but whether diet impacts...
News
FDA OKs capivasertib for certain advanced breast cancers
The FDA also approved a companion diagnostic device, the FoundationOne CDx assay, to identify patients who are eligible for treatment with...
Conference Coverage
Particulate pollution increases the risk for breast cancer
“There is now strong epidemiological and biological evidence for the link between PM2.5 particulate exposure and cancer ...”
News
Low vitamin D linked to paclitaxel-induced peripheral neuropathy
These results also “suggest that vitamin D supplementation in patients with lower levels of vitamin D may reduce peripheral neuropathy ...”
Conference Coverage
T-DXd benefits persist for HER2-low breast cancer
Extended follow-up of DESTINY-Breast04 confirms survival benefit of T-DXd for HER2-low advanced breast cancer.
Conference Coverage
Omitting surgery may be safe in early BC after neoadjuvant pCR
A small trial in early breast cancer has reported 100% disease-free survival at 3 years in women who skipped surgery following pathologic complete...
Conference Coverage
Dato-DXd trumps chemo in advanced HR+/HER2– breast cancer
The antibody-drug conjugate datopotamab deruxtecan had better efficacy and safety than chemotherapy for patients with endocrine-resistant...